HomeCompareDIZTF vs JNJ

DIZTF vs JNJ: Dividend Comparison 2026

DIZTF yields 895.66% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIZTF wins by $7260963.49M in total portfolio value
10 years
DIZTF
DIZTF
● Live price
895.66%
Share price
$0.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7260963.51M
Annual income
$5,953,403,020,932.87
Full DIZTF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DIZTF vs JNJ

📍 DIZTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDIZTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DIZTF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DIZTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DIZTF
Annual income on $10K today (after 15% tax)
$76,130.77/yr
After 10yr DRIP, annual income (after tax)
$5,060,392,567,792.94/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DIZTF beats the other by $5,060,392,567,089.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DIZTF + JNJ for your $10,000?

DIZTF: 50%JNJ: 50%
100% JNJ50/50100% DIZTF
Portfolio after 10yr
$3630481.76M
Annual income
$2,976,701,510,880.33/yr
Blended yield
81.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DIZTF
No analyst data
Altman Z
5.4
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DIZTF buys
0
JNJ buys
0
No recent congressional trades found for DIZTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDIZTFJNJ
Forward yield895.66%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$7260963.51M$20.0K
Annual income after 10y$5,953,403,020,932.87$827.78
Total dividends collected$7159423.26M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DIZTF vs JNJ ($10,000, DRIP)

YearDIZTF PortfolioDIZTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$100,266$89,565.61$10,676$355.77+$89.6KDIZTF
2$946,569$839,285.04$11,407$389.39+$935.2KDIZTF
3$8,417,847$7,405,017.75$12,198$426.53+$8.41MDIZTF
4$70,551,839$61,544,742.48$13,056$467.62+$70.54MDIZTF
5$557,565,343$482,074,875.60$13,987$513.12+$557.55MDIZTF
6$4,157,153,660$3,560,558,742.83$14,998$563.56+$4157.14MDIZTF
7$29,258,606,851$24,810,452,434.95$16,098$619.52+$29258.59MDIZTF
8$194,502,319,400$163,195,610,069.55$17,295$681.69+$194502.30MDIZTF
9$1,222,019,145,437$1,013,901,663,679.28$18,599$750.82+$1222019.13MDIZTF
10$7,260,963,506,551$5,953,403,020,932.87$20,022$827.78+$7260963.49MDIZTF

DIZTF vs JNJ: Complete Analysis 2026

DIZTFStock

Dignitana AB (publ), a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. The company was incorporated in 2007 is headquartered in Lund, Sweden.

Full DIZTF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DIZTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DIZTF vs SCHDDIZTF vs JEPIDIZTF vs ODIZTF vs KODIZTF vs MAINDIZTF vs ABBVDIZTF vs MRKDIZTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.